Risk assessment of new psychoactive substances - EMCDDA - Europa

Risk assessment of new psychoactive substances: operating guidelinesD3.3.D3.4.Characteristics and behaviours of users (including risk factors,vulnerability, etc.).Nature and extent of health consequences (e.g. acute emergencies, roadtraffic accidents).Relevant information may already feature under section D.1. However,factors affecting the potential consequences for others are considered tobe a public health issue (e.g. the likelihood of irresponsible behaviour,the extent of disturbance of executive function, decision making and theability to control one’s movements).D3.5.D3.6.Long-term consequences of use (e.g. irreversible toxicity leading todeterioration of health later in life).Conditions under which the new psychoactive substance is obtained andused, including context-related effects and risks (e.g. continuous dancingin hot environments, other substances used).Section ESocial risksE1. Individual social risksAny effects known to impact on the social functioning of the individualuser, e.g. impact on education or career and effects on personalrelationships.E2. Possible effects on direct social environmentHere, the consequences for the user’s social environment should bementioned, such as neglect of family or violent behaviour.E3. Possible effects on society as a wholeEffects such as disturbance of public order and safety and acquisitivecrime should be described here.E4. Economic costsThe economic impact of the use of the new psychoactive substancenot related to the involvement of organised crime (which is mentionedunder F), such as demands on health care, may be mentioned here.E5. Possible effects related to the cultural context, for example marginalisation52